• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于如何管理血液透析患者严重心律失常的10点建议。

10 tips on how to manage severe arrhythmia in haemodialysis patients.

作者信息

Stamellou Eleni, Georgopoulos Christos, Lakkas Lampros, Dounousi Evangelia

机构信息

Department of Nephrology, University Hospital of Ioannina, Ioannina, Greece.

Department of Nephrology and Clinical Immunology, RWTH Aachen University Hospital, Aachen, Germany.

出版信息

Clin Kidney J. 2025 Mar 7;18(4):sfaf072. doi: 10.1093/ckj/sfaf072. eCollection 2025 Apr.

DOI:10.1093/ckj/sfaf072
PMID:40226367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11986812/
Abstract

Cardiovascular disease, particularly life-threatening ventricular arrhythmias and sudden cardiac death (SCD), remains the leading cause of death among haemodialysis (HD) patients, with an alarmingly higher incidence compared with the general population. By addressing key risk factors such as electrolyte imbalances, fluid overload and ultrafiltration rates, focusing on practical interventions and incorporating multidisciplinary care, clinicians can significantly reduce the risk of fatal arrhythmias. Here we propose 10 practical tips to guide clinicians in managing severe arrhythmias in HD patients. Each tip provides actionable insights for identifying high-risk individuals, with an emphasis on prevention and multidisciplinary care.

摘要

心血管疾病,尤其是危及生命的室性心律失常和心源性猝死(SCD),仍然是血液透析(HD)患者的主要死因,其发病率与普通人群相比高得惊人。通过解决诸如电解质失衡、液体过载和超滤率等关键风险因素,注重实际干预措施并纳入多学科护理,临床医生可以显著降低致命性心律失常的风险。在此,我们提出10条实用建议,以指导临床医生管理HD患者的严重心律失常。每条建议都为识别高危个体提供了可操作的见解,重点在于预防和多学科护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b39/11986812/319108bacfe1/sfaf072fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b39/11986812/6287a3159dfa/sfaf072fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b39/11986812/319108bacfe1/sfaf072fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b39/11986812/6287a3159dfa/sfaf072fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b39/11986812/319108bacfe1/sfaf072fig2.jpg

相似文献

1
10 tips on how to manage severe arrhythmia in haemodialysis patients.关于如何管理血液透析患者严重心律失常的10点建议。
Clin Kidney J. 2025 Mar 7;18(4):sfaf072. doi: 10.1093/ckj/sfaf072. eCollection 2025 Apr.
2
Sudden cardiac death in dialysis patients: different causes and management strategies.透析患者的心脏性猝死:不同病因与管理策略。
Nephrol Dial Transplant. 2021 Feb 20;36(3):396-405. doi: 10.1093/ndt/gfz182.
3
Current Perspectives on Sudden Cardiac Death in Hemodialysis Patients.血液透析患者心源性猝死的当前观点
Contrib Nephrol. 2018;196:5-12. doi: 10.1159/000485690. Epub 2018 Jul 24.
4
Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.强化血液透析、左心室肥厚与心血管疾病。
Am J Kidney Dis. 2016 Nov;68(5S1):S5-S14. doi: 10.1053/j.ajkd.2016.05.025.
5
Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.植入式心脏复律除颤器。预防性应用:基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(14):1-74. Epub 2005 Sep 1.
6
Incidence and Risk Factors of Sudden Cardiac Death in End-Stage Renal Disease Patients Undergoing Hemodialysis: A Retrospective Study.终末期肾病血液透析患者心脏性猝死的发生率及危险因素:一项回顾性研究。
Saudi J Kidney Dis Transpl. 2021 Jul-Aug;32(4):957-966. doi: 10.4103/1319-2442.338307.
7
The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey.左心室肥厚的加重是血液透析患者心源性猝死的最强预测因素:一项为期10年的调查。
Nephrol Dial Transplant. 2004 Jul;19(7):1829-34. doi: 10.1093/ndt/gfh288. Epub 2004 May 5.
8
Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies.扩张型心肌病、肥厚型心肌病、限制型心肌病和致心律失常性右室心肌病中的心源性猝死发生率、风险评估和预防。
Eur J Heart Fail. 2023 Dec;25(12):2144-2163. doi: 10.1002/ejhf.3076. Epub 2023 Nov 14.
9
Are arrhythmias the drivers of sudden cardiac death in heart failure with preserved ejection fraction? A review.心律失常是否是射血分数保留的心力衰竭中猝死的驱动因素?一篇综述。
ESC Heart Fail. 2023 Jun;10(3):1555-1569. doi: 10.1002/ehf2.14248. Epub 2022 Dec 9.
10
Impact of Interdialytic Intervals on Sudden Cardiac Death in Chronic Kidney Disease Stage 5D Patients on a Twice-Weekly Hemodialysis Schedule.透析间期对每周进行两次血液透析的慢性肾脏病5D期患者心源性猝死的影响。
Kidney Blood Press Res. 2025;50(1):420-428. doi: 10.1159/000546184. Epub 2025 May 7.

引用本文的文献

1
Electrophysiology Models for End-Stage Renal Disease Maladaptations That Promote Asystole.促进心脏停搏的终末期肾病适应不良的电生理模型。
Rev Cardiovasc Med. 2025 Jul 30;26(7):37400. doi: 10.31083/RCM37400. eCollection 2025 Jul.

本文引用的文献

1
Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia.对于高钾血症血液透析患者,与单独使用2.0 mmol/l透析液钾浓度相比,3.0 mmol/l透析液钾浓度联合环硅酸锆钠对无透析天数及心律失常发生率的影响。
Kidney Int. 2025 Jan;107(1):169-179. doi: 10.1016/j.kint.2024.10.010. Epub 2024 Oct 26.
2
Implantable Cardioverter Defibrillator and Resynchronization Therapy in Patients With Overt Chronic Kidney Disease: JACC State-of-the-Art Review.埋藏式心脏转复除颤器和再同步治疗在有显性慢性肾脏病患者中的应用:美国心脏病学会的现状评价。
J Am Coll Cardiol. 2024 Oct 1;84(14):1342-1362. doi: 10.1016/j.jacc.2024.05.081.
3
Listening to the Rhythm of Arrhythmias Among Patients Maintained on Hemodialysis.倾听维持性血液透析患者的心律失常节律
Kidney Med. 2024 Feb 19;6(4):100803. doi: 10.1016/j.xkme.2024.100803. eCollection 2024 Apr.
4
Corrected QT Interval and Outcomes of Dialysis Patients with Symptomatic Peripheral Artery Disease: A Prospective Cohort Study.校正QT间期与有症状外周动脉疾病透析患者的预后:一项前瞻性队列研究
J Clin Med. 2024 Jan 23;13(3):654. doi: 10.3390/jcm13030654.
5
Current Knowledge of Beta-Blockers in Chronic Hemodialysis Patients.慢性血液透析患者中β受体阻滞剂的当前知识
Int J Nephrol Renovasc Dis. 2023 Oct 12;16:223-230. doi: 10.2147/IJNRD.S414774. eCollection 2023.
6
Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association.慢性肾脏病的心血管并发症:来自欧洲肾脏病协会的欧洲肾脏和心血管医学工作组的综述。
Cardiovasc Res. 2023 Sep 5;119(11):2017-2032. doi: 10.1093/cvr/cvad083.
7
QT-Prolonging Antibiotics, Serum-to-Dialysate Potassium Gradient, and Risk of Sudden Cardiac Death Among Patients Receiving Maintenance Hemodialysis.接受维持性血液透析患者中,延长QT间期的抗生素、血清与透析液的钾梯度及心源性猝死风险
Kidney Med. 2023 Feb 15;5(5):100618. doi: 10.1016/j.xkme.2023.100618. eCollection 2023 May.
8
Changes in QT Interval in Maintenance Hemodialysis Patients: Pre-Dialysis, One Hour after Initiation of Dialysis, and Post-Dialysis.维持性血液透析患者 QT 间期的变化:透析前、透析开始后 1 小时和透析后。
Blood Purif. 2023;52(5):493-502. doi: 10.1159/000529664. Epub 2023 Mar 30.
9
The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study.血清-透析液钾梯度对血液透析人群中 SSRIs 心血管安全性的修饰作用:一项药物流行病学研究。
Nephrol Dial Transplant. 2022 Oct 19;37(11):2241-2252. doi: 10.1093/ndt/gfac214.
10
European Resuscitation Council Guidelines 2021: Cardiac arrest in special circumstances.欧洲复苏理事会 2021 指南:特殊情况下的心脏骤停。
Resuscitation. 2021 Apr;161:152-219. doi: 10.1016/j.resuscitation.2021.02.011. Epub 2021 Mar 24.